Boditech Med announced on the 2nd that it has obtained product registration approval for the COVID-19 antigen diagnosis kit from India's Central Medicine Standards Management Organization (CDOCO).
Boditech Med has an opportunity to enter the Indian market.
India recently announced a plan to approve the use of overseas products related to COVID-19 as social turmoil increased due to a series of confirmed cases of COVID-19.
Boditech Med has also completed product registration for a total of 11 diagnostic kits, including the Covid-19 antigen diagnosis kit approved this time.
Reporter Lee Ji-sun stockmk2020@gmail.com
저작권자 © 인포스탁데일리 무단전재 및 재배포 금지
